Evaluation of antimicrobial activity of extracts of Tibouchina candolleana (melastomataceae), isolated compounds and semi-synthetic derivatives against endodontic bacteria
AUTOR(ES)
Santos, Fernanda M. dos, Souza, Maria Gorete de, Crotti, Antônio E. Miller, Martins, Carlos H. G., Ambrósio, Sérgio R., Veneziani, Rodrigo C. S., Silva, Márcio L. Andrade e, Cunha, Wilson R.
FONTE
Brazilian Journal of Microbiology
DATA DE PUBLICAÇÃO
2012-06
RESUMO
This work describes the phytochemical study of the extracts from aerial parts of Tibouchina candolleana as well as the evaluation of the antimicrobial activity of extracts, isolated compounds, and semi-synthetic derivatives of ursolic acid against endodontic bacteria. HRGC analysis of the n-hexane extract of T. candolleana allowed identification of b-amyrin, a-amyrin, and b-sitosterol as major constituents. The triterpenes ursolic acid and oleanolic acid were isolated from the methylene chloride extract and identified. In addition, the flavonoids luteolin and genistein were isolated from the ethanol extract and identified. The antimicrobial activity was investigated via determination of the minimum inhibitory concentration (MIC) using the broth microdilution method. Amongst the isolated compounds, ursolic acid was the most effective against the selected endodontic bacteria. As for the semi-synthetic ursolic acid derivatives, only the methyl ester derivative potentiated the activity against Bacteroides fragilis.
Documentos Relacionados
- Antimicrobial activity of the myrsinoic acid A from Myrsine coriacea and the semi-synthetic derivatives
- Antimicrobial Potential of Natural and Semi-Synthetic ent-Kaurane and ent-Pimarane Diterpenes against Clinically Isolated Gram-Positive Multidrug-Resistant Bacteria
- Bergenin of Peltophorum dubium (Fabaceae) Roots and Its Bioactive Semi-Synthetic Derivatives
- Biological activity of neosergeolide and isobrucein B (and two semi-synthetic derivatives) isolated from the Amazonian medicinal plant Picrolemma sprucei (Simaroubaceae)
- Current Antimalarial Therapies and Advances in the Development of Semi-Synthetic Artemisinin Derivatives